Moon Surgical
Paris and San Carlos, California developer of the Maestro system, a collaborative robot that assists surgeons in laparoscopic surgery.
Moon Surgical, originally called MastOR, was founded in Paris in 2020 by surgeon Brice Gayet as a portfolio company of Sofinnova Partners' MD Start, and has offices in Paris and San Carlos, California. Anne Osdoit is chief executive. Its Maestro system is a collaborative robot designed to be used in laparoscopy in any operating room. Maestro received CE marking in April 2023 and FDA clearance for its commercial version in June 2024, and in March 2025 the company announced FDA clearance for ScoPilot, an AI-enhanced intraoperative capability on Maestro. In June 2022 it announced a $31.3 million Series A led by GT Healthcare Capital & Partners with Johnson & Johnson Innovation (JJDC), Cathay Health and existing investor Sofinnova Partners, alongside individual medtech leaders. In May 2023 it raised a further $55.4 million co-led by Sofinnova Partners through its Capital Strategy fund and NVIDIA's NVentures, and named Fred Moll, MD, as chair of its board.
- Latest funding
- $55.4M
- Total funding
- $86.7M
- Latest valuation
- —
- Founded
- 2020
- Country
- France
- May 17, 2023Additional funding$55.4M
- Jun 7, 2022Series A$31.3M